IMG-7289 in Patients With Myelofibrosis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 15
Summary
- Conditions
- Myelofibrosis
- Post-essential Thrombocythemia Myelofibrosis (PET-MF)
- Post-polycythemia Vera Myelofibrosis (PPV-MF)
- Primary Myelofibrosis (PMF)
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
With enrollment complete in Phase 1/2a, expansion into Phase 2b has occurred. New patients will be enrolled into Phase 2b study.
With enrollment complete in Phase 1/2a, expansion into Phase 2b has occurred. New patients will be enrolled into Phase 2b study.
Tracking Information
- NCT #
- NCT03136185
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Kristen Pettit University of Michigan
Get Well Soon